Faculty profile

Maryam Oskoui

ResearcherNeurology and NeurosurgeryMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses may be missing. Find their university profile.

Maryam Oskoui

Researcher

Neurology and Neurosurgery

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
68 publications in the last five years, latest in 2026.
Senior (last) author on 15 recent papers, a sign of leading a research group.
Principal investigator on 6 research grants (6 CIHR), most recently in 2024.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

140

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Gene Therapy Neurology Exergaming Pragmatic Randomized Controlled Trial Rare Disease Registry-Based Trial Rehabilitation Spinal Muscular Atrophy

Latest papers

Characteristics of unilateral cerebral palsy according to gestational age at birth: A retrospective study.
Developmental medicine and child neurology · 2026
Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations: Report of the AAN Guidelines Subcommittee and the American Headache Society.
Neurology · 2026
Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations: Report of the AAN Guidelines Subcommittee and the American Headache Society.
Headache · 2026

All 140 publications

Latest funding

Resolving roadblocks to clinical trial readiness for rare brain disease gene therapy
CIHR · 2024 · Principal investigator
$1,137,500
Developing Gene Therapies for Rare Brain Disorders
CIHR · 2023 · Principal investigator
Exergaming registry-based trial promoting physical activity in children and adolescents with spinal muscular atrophy
CIHR · 2022 · Nominated PI
$444,274

All 7 grants and awards

140 publications.

Characteristics of unilateral cerebral palsy according to gestational age at birth: A retrospective study.

Piché JV, Hussein N, Kirton A, Fehlings D, Oskoui M, Shevell M, Dunbar M

Developmental medicine and child neurology2026

DOI: 10.1111/dmcn.70177 PMID: 41670174

Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations: Report of the AAN Guidelines Subcommittee and the American Headache Society.

Potrebic S, Tanveer S, Becker WJ, Burch R, Cooke LJ, Fenton T, Fletcher JJ, Gordon Perue GL, Hershey AD, Jackson JL, Kessel S, Loder EW, Minen MT, Oskoui M, Ramanan VK, Murren M, Schwedt TJ, Silberstein SD, Smith DB, Botchway-Doe KA, Silsbee HM, Pringsheim T

Neurology2026

DOI: 10.1212/wnl.0000000000214881 PMID: 42673560

Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations: Report of the AAN Guidelines Subcommittee and the American Headache Society.

Headache2026

DOI: 10.1111/head.70199 PMID: 42673606

Systematic Review of Pharmacologic Treatment for Migraine Prevention in Adults: Report of the AAN Guidelines Subcommittee and the American Headache Society.

Pringsheim T, Smith DB, Tanveer S, Becker WJ, Burch R, Cooke LJ, Fenton T, Fletcher JJ, Gordon Perue GL, Hershey AD, Jackson JL, Kessel S, Loder EW, Minen MT, Oskoui M, Ramanan VK, Murren M, Schwedt TJ, Silberstein SD, Botchway-Doe KA, Silsbee HM, Potrebic S

Headache2026

DOI: 10.1111/head.70200 PMID: 42673583

Predicting Functional Decline in Duchenne Muscular Dystrophy: Advancing Trial Readiness and Patient Counseling.

McMillan HJ, Oskoui M

Neurology2026Senior author

DOI: 10.1212/wnl.0000000000214882 PMID: 42190149

Vamorolone Safety, Pharmacokinetics, and Exploratory Efficacy in Duchenne Muscular Dystrophy: A Phase II, Nonrandomized, Multiple-Dose Study in 2-<4-Year-Old Boys.

Mah JK, Gonorazky HD, Nigro E, Lochmüller H, Alemán A, Yaworski A, Oskoui M, Sbrocchi AM, Selby KA, de Vera A, Mathur R, Gresko E, Linden A, Dutreix C, Hoffman EP

Neurology2026

DOI: 10.1212/wnl.0000000000218066 PMID: 42139656

Results of a phase II open-label, multiple-dose study of vamorolone (VBP15-006) in 7- to < 18-year-old boys with duchenne muscular dystrophy.

Lochmüller H, Gonorazky H, Nigro E, Mah JK, Alemán A, Yaworski A, Oskoui M, Sbrocchi AM, Selby K, de Vera A, McAdam L, Gresko E, Linden A, Dutreix C, Hoffman EP

Journal of neurology2026

DOI: 10.1007/s00415-026-13711-6 PMID: 41774261

Broad lessons from negative trials in rare diseases.

Servais L, Oskoui M

The Lancet. Neurology2026Senior author

DOI: 10.1016/s1474-4422(26)00038-4 PMID: 41722576

Author Correction: Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial.

Kwon JM, Munell F, Le Goff L, Yuge K, Kato T, Cances C, De Waele L, Woodcock IR, Mercuri EM, Proud CM, Darras BT, Hayes LH, Oskoui M, Visootsak J, Williams G, Ilić A, Yang L, van der Pol WL

Nature medicine2026

DOI: 10.1038/s41591-026-04233-9 PMID: 41606122

Systematic Review of Pharmacologic Treatment for Migraine Prevention in Adults: Report of the AAN Guidelines Subcommittee and the American Headache Society.

Neurology2026

DOI: 10.1212/wnl.0000000000218112 PMID: 42673559

Resolving roadblocks to clinical trial readiness for rare brain disease gene therapy

Principal investigatorCIHR2024Operating Grant:Bringing Rare Disease Gene Therapies to Clinical Trial Readiness

Principal investigators: Ernst, Carl P; Rouleau, Guy A; Cléry, Justine C; Farhan, Sali M; Gentil, Benoit J; Karamchandani, Jason; Murai, Keith; Myers, Kenneth A; Oskoui, Maryam; Pandolfo, Massimo

Keywords: Gene Therapy; Genetic Engineering; Marmoset; Neurology

$1,137,500

Developing Gene Therapies for Rare Brain Disorders

Principal investigatorCIHR2023Op. Grant :Bringing Rare Disease Gene Therapies to Clinical Trial Readiness- LOI

Principal investigators: Ernst, Carl P; Cléry, Justine C; Gentil, Benoit J; Oskoui, Maryam; Pandolfo, Massimo

Keywords: Antisense Oligonucleotides; Gene Therapy; Neurodevelopment; Neurology; Virus

Exergaming registry-based trial promoting physical activity in children and adolescents with spinal muscular atrophy

Nominated PICIHR2022Operating Grant: Clinical Trials Projects - Indirect Costs

Principal investigators: Oskoui, Maryam; Smith, Maureen M; Evans, Alan C; Iturria Medina, Yasser; Levac, Danielle E; Potter, Elizabeth K

Keywords: Exergaming; Pragmatic Randomized Controlled Trial; Rare Disease; Registry-Based Trial; Rehabilitation; Spinal Muscular Atrophy; Wearable Technology

$444,274

Exergaming registry-based trial promoting physical activity in children and adolescents with spinal muscular atrophy

Nominated PICIHR2022Operating Grant: Clinical Trials Projects

Principal investigators: Oskoui, Maryam; Smith, Maureen M; Evans, Alan C; Iturria Medina, Yasser; Levac, Danielle E; Potter, Elizabeth K

Keywords: Exergaming; Pragmatic Randomized Controlled Trial; Rare Disease; Registry-Based Trial; Rehabilitation; Spinal Muscular Atrophy; Wearable Technology

$1,777,095

Genetic Insights to the Causes of Cerebral Palsy

Nominated PICIHR2016Project Grant

Principal investigators: Oskoui, Maryam; Fehlings, Darcy L

Keywords: Cerebral Palsy; Developmental Disability; Family Empowerment; Genetics; Parental Stress; Whole Genome Sequencing

$600,524

CP square: Engaging Community Partners for Children Participation

Co-investigatorCIHR2014Planning and Dissemination Grant - Institute Community Support

Principal investigators: Shikako, Keiko

Keywords: Cerebral Palsy; Environmental Scan; Integrated Knowledge Creation; Participation; Policy

$12,500

Prevalence and healthcare utilization pattern of children with cerebral palsy in Quebec

Nominated PICIHR2011Operating Grant: SickKids-CIHR-IHDCYH New Investigator Grants

Principal investigators: Oskoui, Maryam

Keywords: Healthcare Services; Population Health

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Maryam Oskoui

Research

Latest papers

Latest funding

Characteristics of unilateral cerebral palsy according to gestational age at birth: A retrospective study.

Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations: Report of the AAN Guidelines Subcommittee and the American Headache Society.

Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations: Report of the AAN Guidelines Subcommittee and the American Headache Society.

Systematic Review of Pharmacologic Treatment for Migraine Prevention in Adults: Report of the AAN Guidelines Subcommittee and the American Headache Society.

Predicting Functional Decline in Duchenne Muscular Dystrophy: Advancing Trial Readiness and Patient Counseling.

Vamorolone Safety, Pharmacokinetics, and Exploratory Efficacy in Duchenne Muscular Dystrophy: A Phase II, Nonrandomized, Multiple-Dose Study in 2-<4-Year-Old Boys.

Results of a phase II open-label, multiple-dose study of vamorolone (VBP15-006) in 7- to&#x2009;<&#x2009;18-year-old boys with duchenne muscular dystrophy.

Broad lessons from negative trials in rare diseases.

Author Correction: Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial.

Systematic Review of Pharmacologic Treatment for Migraine Prevention in Adults: Report of the AAN Guidelines Subcommittee and the American Headache Society.

Resolving roadblocks to clinical trial readiness for rare brain disease gene therapy

Developing Gene Therapies for Rare Brain Disorders

Exergaming registry-based trial promoting physical activity in children and adolescents with spinal muscular atrophy

Exergaming registry-based trial promoting physical activity in children and adolescents with spinal muscular atrophy

Genetic Insights to the Causes of Cerebral Palsy

CP square: Engaging Community Partners for Children Participation

Prevalence and healthcare utilization pattern of children with cerebral palsy in Quebec

Frequent collaborators

Adam Kirton

Darcy Fehlings

Tamara Pringsheim

Mary Dunbar

Annette Majnemer

Craig Campbell

Deborah Dewey

Nicole Letourneau

Adam Kirton

Patricia Li

Evelyn Constantin

Evelyn Constantin

Patricia Li

Angela Genge

Seungmi Yang

Pranesh Chakraborty

Bernard Brais

Lawrence Korngut

Pia Wintermark

Jodi Warman Chardon

David Buckley

Christina Wolfson

Myriam Srour

Davide Martino

Darcy Fehlings

Gerald Pfeffer

Gabrielle Freire

Martin Offringa

Julian Little

Michael Shevell

Christina Wolfson

Danielle Levac

Cynthia Gagnon

Gregory Costain

Sirui Zhou

Giulia Fadda

Roberta La Piana

Kenneth Myers

Jack Antel

Ronit Mesterman

Results of a phase II open-label, multiple-dose study of vamorolone (VBP15-006) in 7- to < 18-year-old boys with duchenne muscular dystrophy.